{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:04:36Z","timestamp":1793822676988,"version":"4.6.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.genhosppsych.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:01:09Z","timestamp":1770739269000},"page":"179-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Ketamine combined with psychotherapy for treatment-resistant depression: Real-world outcomes and the role of subjective experience"],"prefix":"10.1016","volume":"99","author":[{"given":"Rebeca","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Marguilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o Matos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"Franklin","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Castro-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10189","key":"10.1016\/j.genhosppsych.2026.02.001_bb0005","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S0140-6736(18)32408-5","article-title":"Reducing the global burden of depression: a Lancet\u2013World Psychiatric Association Commission","volume":"393","author":"Herrman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0010","author":"World Health Organization"},{"issue":"11","key":"10.1016\/j.genhosppsych.2026.02.001_bb0015","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr Serv"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0025","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r11470","article-title":"Trajectories of acute antidepressant efficacy: how long to wait for response? A systematic review and meta-analysis of long-term, placebo-controlled acute treatment trials","volume":"79","author":"Henssler","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0030","series-title":"The Maudsley prescribing guidelines in psychiatry","author":"Taylor","year":"2018"},{"issue":"9","key":"10.1016\/j.genhosppsych.2026.02.001_bb0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J Psychopharmacol"},{"issue":"11","key":"10.1016\/j.genhosppsych.2026.02.001_bb0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archpsyc.58.11.1085","article-title":"Ethical dilemmas in prescribing antidepressants","volume":"58","author":"Gregory","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0045","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0050","series-title":"Acta Psiquiatrica y Psicologia de America Latina","article-title":"Antidepressive therapy with Cl 581","author":"Fontana","year":"1974"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0055","series-title":"Operaci\u00f3n Mazateca: estudio de hongos y otras plantas alucin\u00f3genas mexicanas: tratamiento psicoterap\u00e9utico de psicos\u00edntesis","author":"Roquet","year":"1971"},{"issue":"6","key":"10.1016\/j.genhosppsych.2026.02.001_bb0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0033-3182(73)71306-2","article-title":"The use of ketamine in psychiatry","volume":"14","author":"Khorramzadeh","year":"1973","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.genhosppsych.2026.02.001_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/02791072.1997.10400185","article-title":"Ketamine psychedelic therapy (KPT): a review of the results of ten years of research","volume":"43","author":"Krupitsky","year":"2011","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.genhosppsych.2026.02.001_bb0075","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/da.22505","article-title":"Ketamine for treatment-resistant unipolar and bipolar major depression: critical review and implications for clinical practice","volume":"33","author":"Bobo","year":"2016","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0080","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment-resistant depression: January 2009\u2013January 2019","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1016\/j.genhosppsych.2026.02.001_bb0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.genhosppsych.2026.02.001_bb0090","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"25","key":"10.1016\/j.genhosppsych.2026.02.001_bb0095","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0100","article-title":"Ketamine versus ECT for major depression: flawed evidence base","author":"Braithwaite","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jad.2023.02.152","article-title":"Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: a systematic review and meta-analysis","volume":"330","author":"de Sim\u00f5es Moreira","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2023.11.023","article-title":"Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: a systematic review and network meta-analysis","volume":"346","author":"Terao","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jad.2024.01.165","article-title":"Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study","volume":"350","author":"Vestring","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jad.2024.01.207","article-title":"Ketamine for major depressive disorder during an inpatient psychiatric admission: effectiveness, adverse events, and lessons learned","volume":"351","author":"Brody","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jad.2023.10.120","article-title":"A systematic review of the incidence of medical serious adverse events in sub-anesthetic ketamine treatment of psychiatric disorders","volume":"345","author":"Hovda","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2024.02.052","article-title":"Cognitive outcomes from the randomised, active-controlled ketamine for adult depression study (KADS)","volume":"352","author":"Martin","year":"2024","journal-title":"J Affect Disord"},{"issue":"Pt 1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0145","article-title":"Ketamine for refractory depression: save the best for last?","author":"Nigam","year":"2024","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20190-4","article-title":"The role of dissociation in ketamine\u2019s antidepressant effects","volume":"11","author":"Ballard","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.genhosppsych.2026.02.001_bb0155","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"10.1016\/j.genhosppsych.2026.02.001_bb0160","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0269881121998321","article-title":"A qualitative and quantitative account of patients\u2019 experiences of ketamine and its antidepressant properties","volume":"35","author":"Sumner","year":"2021","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.02.001_bb0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.euroneuro.2019.02.005","article-title":"Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder","volume":"29","author":"Aust","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2026.02.001_bb0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/02698811221140011","article-title":"A unified model of ketamine\u2019s dissociative and psychedelic properties","volume":"37","author":"Marguilho","year":"2023","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/nc\/nix016","article-title":"Self unbound: ego dissolution in psychedelic experience","volume":"2017","author":"Letheby","year":"2017","journal-title":"Neurosci Conscious"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0190","article-title":"The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression","volume":"14","author":"Garel","year":"2023","journal-title":"Front Psych"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1177\/07067437241245384","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults","author":"Lam","year":"2024","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0200","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/bdi.13035","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disord"},{"issue":"10","key":"10.1016\/j.genhosppsych.2026.02.001_bb0205","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.7326\/M22-1603","article-title":"The management of major depressive disorder: synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline","volume":"175","author":"McQuaid","year":"2022","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.genhosppsych.2026.02.001_bb0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.22501","article-title":"Ketamine\u2019s mechanism of action: a path to rapid-acting antidepressants","volume":"33","author":"Abdallah","year":"2016","journal-title":"Depress Anxiety"},{"issue":"7","key":"10.1016\/j.genhosppsych.2026.02.001_bb0215","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00213-021-05825-8","article-title":"Efficacy of ketamine for major depressive episodes at 2, 4, and 6 weeks post-treatment: a meta-analysis","volume":"238","author":"Conley","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0220","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2147\/NDT.S117146","article-title":"Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies","volume":"12","author":"Han","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0225","first-page":"63","article-title":"Efficacy of ketamine in the treatment of major depressive episodes: a systematic review and meta-analysis of individual participant data","volume":"210","author":"Papadimitropoulou","year":"2017","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.genhosppsych.2026.02.001_bb0230","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","article-title":"Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression","volume":"230","author":"Romeo","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2022.07.030","article-title":"Active mechanisms of ketamine-assisted psychotherapy: a systematic review","volume":"315","author":"Joneborg","year":"2022","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive behavioral therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychother Psychosom"},{"issue":"5","key":"10.1016\/j.genhosppsych.2026.02.001_bb0245","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0250","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuropharm.2018.01.005","article-title":"A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: results from a randomized, controlled laboratory study","volume":"142","author":"Dakwar","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.genhosppsych.2026.02.001_bb0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","article-title":"Adjunctive ketamine with relapse prevention\u2013based psychological therapy in the treatment of alcohol use disorder","volume":"179","author":"Grabski","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-022-04268-5","article-title":"Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study","volume":"22","author":"Ahuja","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0265","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review and meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0270","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jad.2023.04.141","article-title":"The effects of ketamine on symptoms of depression and anxiety in real-world care settings: a retrospective controlled analysis","volume":"335","author":"Hietamies","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0275","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jad.2021.12.097","article-title":"A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings","volume":"301","author":"McInnes","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"Mini International Neuropsychiatric Interview (MINI): valida\u00e7\u00e3o de entrevista breve para o diagn\u00f3stico de transtornos mentais","volume":"22","author":"Amorim","year":"2000","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"The validity of the mini international neuropsychiatric interview (MINI) according to the SCID-P and its reliability","volume":"12","author":"Sheehan","year":"1997","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0290","series-title":"Psychodynamic therapy: a guide to evidence-based practice","author":"Summers","year":"2012"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1177\/2164957X221081113","article-title":"Psychedelic psychotherapy: building wholeness through connection","volume":"11","author":"Vaid","year":"2022","journal-title":"Glob Adv Health Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cpr.2009.08.010","article-title":"The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis","volume":"30","author":"Driessen","year":"2010","journal-title":"Clin Psychol Rev"},{"issue":"3\u20134","key":"10.1016\/j.genhosppsych.2026.02.001_bb0305","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/10503309412331334012","article-title":"The core conflictual relationship theme","volume":"4","author":"Luborsky","year":"1994","journal-title":"Psychother Res"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0310","article-title":"Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective\u2014a new and evolving approach","volume":"15","author":"Wolfson","year":"2024","journal-title":"Front Psych"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0315","series-title":"Communicative structures and psychic structures: a psychoanalytic interpretation of communication","first-page":"367","article-title":"Measuring a pervasive psychic structure in psychotherapy: The core conflictual relationship theme","author":"Luborsky","year":"1977"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0320","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnhum.2016.00269","article-title":"Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI)","volume":"10","author":"Nour","year":"2016","journal-title":"Front Hum Neurosci"},{"issue":"9","key":"10.1016\/j.genhosppsych.2026.02.001_bb0325","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/02698811211066709","article-title":"Validation of the psychological insight scale: a new scale to assess psychological insight following a psychedelic experience","volume":"36","author":"Peill","year":"2022","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.02.001_bb0335","first-page":"287","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharm Stat J Appl Stat Pharm Industry"},{"issue":"7","key":"10.1016\/j.genhosppsych.2026.02.001_bb0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/ph13070151","article-title":"Safety of repeated administration of parenteral ketamine for depression","volume":"13","author":"Feifel","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.02.001_bb0345","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2019.03.071","article-title":"A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation","volume":"251","author":"Zhan","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0355","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J Affect Disord"},{"issue":"12","key":"10.1016\/j.genhosppsych.2026.02.001_bb0360","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/appi.ajp.20220216","article-title":"A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: a randomized clinical trial","volume":"179","author":"Price","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0365","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/wps.21138","article-title":"From treatment resistance to sequential treatments of depression","volume":"22","author":"Cuijpers","year":"2023","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0370","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0375","series-title":"LSD psychotherapy","author":"Grof","year":"1980"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.02.001_bb0380","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/pharmrev.121.000508","article-title":"Neural mechanisms and psychology of psychedelic ego dissolution","volume":"74","author":"Stoliker","year":"2022","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopsych.2013.08.009","article-title":"The effects of sub-anesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers","volume":"76","author":"Dakwar","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0390","first-page":"74","article-title":"Psilocybin-induced alterations in consciousness and serotonin 2A receptor activation","volume":"1","author":"Studerus","year":"2010","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.genhosppsych.2026.02.001_bb0395","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0400","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J Contextual Behav Sci"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0405","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2022.12.042","article-title":"Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms","volume":"324","author":"Nikolaidis","year":"2023","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0410","doi-asserted-by":"crossref","DOI":"10.1093\/nc\/niad017","article-title":"Pattern breaking: a complex systems approach to psychedelic medicine","volume":"2023","author":"Hip\u00f3lito","year":"2023","journal-title":"Neurosci Conscious"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0415","doi-asserted-by":"crossref","DOI":"10.1177\/02698811241249698","article-title":"Measuring psychotherapeutic processes in the context of psychedelic experiences: validation of the general change mechanisms questionnaire (GCMQ)","author":"Wolff","year":"2024","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10503309712331331843","article-title":"Research-informed psychotherapy","volume":"7","author":"Grawe","year":"1997","journal-title":"Psychother Res"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0425","series-title":"Psychological therapy","author":"Grawe","year":"2004"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0430","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always assist psychotherapy?","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","volume":"11","author":"Gr\u00fcnder","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.02.001_bb0440","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/appi.ajp.20230664","article-title":"Is poorly assisted psilocybin treatment an increasing risk?","volume":"181","author":"Schenberg","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2026.02.001_bb0445","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0450","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0455","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.genhosppsych.2026.02.001_bb0460","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 study","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0465","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/mp.2016.249","article-title":"Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders","volume":"22","author":"Zarate","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2026.02.001_bb0470","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/02791072.2019.1587556","article-title":"Ketamine-assisted psychotherapy (KAP): patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy","volume":"51","author":"Dore","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0475","series-title":"The process of psychotherapy: Causation and chance","author":"Tschacher","year":"2019"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0480","first-page":"12","article-title":"Instability and uncertainty are critical for psychotherapy: how the therapeutic alliance opens us up","author":"Connolly","year":"2022","journal-title":"Front Psychol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.02.001_bb0485","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1037\/a0036505","article-title":"The role of mentalizing and epistemic trust in the therapeutic relationship","volume":"51","author":"Fonagy","year":"2014","journal-title":"Psychotherapy (Chic)"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0490","series-title":"Emotional climate: How we relate to emotions and how they affect our daily lives","author":"Mehrabian","year":"2006"},{"issue":"7966","key":"10.1016\/j.genhosppsych.2026.02.001_bb0495","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.genhosppsych.2026.02.001_bb0500","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.neuron.2025.09.010","article-title":"Synaptic priming: a framework for pharmacotherapy in depression","volume":"113","author":"Brown","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0505","article-title":"Psychedelic skepticism: back to the sixties?","volume":"14","author":"Schenberg","year":"2024","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2026.02.001_bb0510","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","article-title":"Self-blinding citizen science to explore psychedelic microdosing","volume":"10","author":"Szigeti","year":"2021","journal-title":"eLife"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834326000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834326000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:04:17Z","timestamp":1778288657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834326000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":102,"alternative-id":["S0163834326000289"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2026.02.001","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine combined with psychotherapy for treatment-resistant depression: Real-world outcomes and the role of subjective experience","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}